123 related articles for article (PubMed ID: 9167214)
1. Anti-inflammatory effects of beraprost sodium, a stable analogue of PGI2, and its mechanisms.
Ueno Y; Koike H; Annoh S; Nishio S
Prostaglandins; 1997 Apr; 53(4):279-89. PubMed ID: 9167214
[TBL] [Abstract][Full Text] [Related]
2. Protective effect of beraprost sodium, a stable prostacyclin analogue, in development of monocrotaline-induced pulmonary hypertension.
Miyata M; Ueno Y; Sekine H; Ito O; Sakuma F; Koike H; Nishio S; Nishimaki T; Kasukawa R
J Cardiovasc Pharmacol; 1996 Jan; 27(1):20-6. PubMed ID: 8656653
[TBL] [Abstract][Full Text] [Related]
3. General pharmacology of beraprost sodium. 2nd communication: effect on the autonomic, cardiovascular and gastrointestinal systems, and other effects.
Murata T; Murai T; Kanai T; Ogaki Y; Sanai K; Kanda H; Sato S; Kajikawa N; Umetsu T; Matsuura H
Arzneimittelforschung; 1989 Aug; 39(8):867-76. PubMed ID: 2510743
[TBL] [Abstract][Full Text] [Related]
4. Effects of beraprost sodium, a stable analogue of prostacyclin, on hyperplasia, hypertrophy and glycosaminoglycan synthesis of rat aortic smooth muscle cells.
Koh E; Morimoto S; Jiang B; Inoue T; Nabata T; Kitano S; Yasuda O; Fukuo K; Ogihara T
Artery; 1993; 20(5):242-52. PubMed ID: 8141645
[TBL] [Abstract][Full Text] [Related]
5. Beneficial effects of beraprost sodium, a stable prostacyclin analogue, in diabetic cardiomyopathy.
Ueno Y; Koike H; Nishio S
J Cardiovasc Pharmacol; 1995 Oct; 26(4):603-7. PubMed ID: 8569222
[TBL] [Abstract][Full Text] [Related]
6. [Effects of beraprost sodium (a PGI2 derivative) on chronic hypoxic pulmonary hypertension in the rat].
Saito M; Tatsumi K; Kasahara Y; Tani T; Kuriyama T
Nihon Kyobu Shikkan Gakkai Zasshi; 1995 May; 33(5):497-504. PubMed ID: 7609334
[TBL] [Abstract][Full Text] [Related]
7. Effect of beraprost sodium on the increased transendothelial permeation of albumin induced by high concentration of glucose.
Kobayashi K; Umeda F; Hashimoto T; Mimura K; Yamashita T; Nawata H
Fukuoka Igaku Zasshi; 1997 Mar; 88(3):44-8. PubMed ID: 9103700
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of B1 receptor mediating des-Arg9-BK-induced rat paw oedema by systemic treatment with bacterial endotoxin.
Campos MM; Souza GE; Calixto JB
Br J Pharmacol; 1996 Mar; 117(5):793-8. PubMed ID: 8851492
[TBL] [Abstract][Full Text] [Related]
9. Effect of beraprost sodium, a stable prostacyclin analogue, on pulmonary thromboembolism in mice.
Ueno Y; Kawashima A; Koike H; Nishio S
Thromb Res; 1995 Jan; 77(2):193-8. PubMed ID: 7740511
[No Abstract] [Full Text] [Related]
10. Effect of beraprost sodium on peripheral circulatory disturbances induced by various stimuli.
Nishio S; Yamada N; Endoh T; Isogaya M; Fukatsu Y; Nishimura S; Kanai N; Umetsu T
Arzneimittelforschung; 1989 Oct; 39(10):1229-34. PubMed ID: 2514691
[TBL] [Abstract][Full Text] [Related]
11. Comparative effects of beraprost, a stable analogue of prostacyclin, with PGE(1), nitroglycerin and nifedipine on canine model of vasoconstrictive pulmonary hypertension.
Tamura M; Kurumatani H; Matsushita T
Prostaglandins Leukot Essent Fatty Acids; 2001 Mar; 64(3):197-202. PubMed ID: 11334556
[TBL] [Abstract][Full Text] [Related]
12. Beraprost sodium, a stable prostacyclin analogue, elicits dilation of isolated porcine retinal arterioles: roles of eNOS and potassium channels.
Ono S; Nagaoka T; Omae T; Tanano I; Kamiya T; Otani S; Ishibazawa A; Yoshida A
Invest Ophthalmol Vis Sci; 2014 Jul; 55(9):5752-9. PubMed ID: 25082887
[TBL] [Abstract][Full Text] [Related]
13. A combination of oral sildenafil and beraprost ameliorates pulmonary hypertension in rats.
Itoh T; Nagaya N; Fujii T; Iwase T; Nakanishi N; Hamada K; Kangawa K; Kimura H
Am J Respir Crit Care Med; 2004 Jan; 169(1):34-8. PubMed ID: 14525801
[TBL] [Abstract][Full Text] [Related]
14. Inhibition by beraprost sodium of thrombin-induced increase in endothelial macromolecular permeability.
Imai-Sasaki R; Kainoh M; Ogawa Y; Ohmori E; Asai Y; Nakadate T
Prostaglandins Leukot Essent Fatty Acids; 1995 Aug; 53(2):103-8. PubMed ID: 7480071
[TBL] [Abstract][Full Text] [Related]
15. Platelet-aggregation inhibition and hemodynamic effects of beraprost sodium, a new oral prostacyclin derivative: a study in healthy male subjects.
Nony P; Ffrench P; Girard P; Delair S; Azoulay S; Girre JP; Dechavanne M; Boissel JP
Can J Physiol Pharmacol; 1996 Aug; 74(8):887-93. PubMed ID: 8960377
[TBL] [Abstract][Full Text] [Related]
16. The modulation of inflammatory oedema by calcitonin gene-related peptide.
Newbold P; Brain SD
Br J Pharmacol; 1993 Mar; 108(3):705-10. PubMed ID: 7682134
[TBL] [Abstract][Full Text] [Related]
17. Effects of beraprost sodium, a prostacyclin analogue, on tail flick response in two models of diabetic-neuropathy in rats and its mechanism.
Ueno Y; Koike H; Annoh S; Nishio S
Life Sci; 1996; 59(9):PL105-10. PubMed ID: 8761032
[TBL] [Abstract][Full Text] [Related]
18. Role of hepatocyte growth factor in endothelial regulation: prevention of high D-glucose-induced endothelial cell death by prostaglandins and phosphodiesterase type 3 inhibitor.
Morishita R; Higaki J; Hayashi SI; Yo Y; Aoki M; Nakamura S; Moriguchi A; Matsushita H; Matsumoto K; Nakamura T; Ogihara T
Diabetologia; 1997 Sep; 40(9):1053-61. PubMed ID: 9300242
[TBL] [Abstract][Full Text] [Related]
19. Involvement of B1 and B2 receptors in bradykinin-induced rat paw oedema.
Campos MM; Calixto JB
Br J Pharmacol; 1995 Mar; 114(5):1005-13. PubMed ID: 7780633
[TBL] [Abstract][Full Text] [Related]
20. Prostaglandin I2 as a potentiator of acute inflammation in rats.
Komoriya K; Ohmori H; Azuma A; Kurozumi S; Hashimoto Y; Nicolaou KC; Barnette WE; Magolda RL
Prostaglandins; 1978 Apr; 15(4):557-64. PubMed ID: 353901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
